---
figid: PMC9353242__ol-24-03-13414-g01
pmcid: PMC9353242
image_filename: ol-24-03-13414-g01.jpg
figure_link: /pmc/articles/PMC9353242/figure/f2-ol-24-03-13414/
number: Figure 2
figure_title: ''
caption: Related homolog genes (e.g. QKI), transcription factors (e.g. NANOG) and
  sialidase (e.g. NEU4) are able to activate the HH signaling pathway to maintain
  the self-renewal ability of GSCs by increasing SHH/GLI1 expression. ID1 and DLG5
  inhibit cullin-3 ubiquitin ligase, activate HH signaling and promote GSC proliferation
  and tumorigenicity. DRP5 is specifically upregulated in the proneural subtype of
  GSC. NS activates the Wnt and HH signaling pathways by regulating the β/AKT axis
  of β-catenin and Gli1, respectively. Vascular endothelial cells in the tumor microenvironment
  may provide SHH to further activate HH signaling pathways, thereby promoting GSC
  properties. QKI, Quaking homolog; DRP5, dihydro pyrimidine-associated protein 5;
  SHH, Sonic Hedgehog; GBM, glioblastoma; SMO, smoothened; Gli, glioma-associated
  oncogene; GSC, glioblastoma stem cells; ID1, differentiation inhibitor 1; NS, microenvironmental
  nutritional stress; DLG5, discs large homolog 5.
article_title: Hedgehog signaling regulates the development and treatment of glioblastoma.
citation: Hongping Wang, et al. Oncol Lett. 2022 Sep;24(3):294.
year: '2022'

doi: 10.3892/ol.2022.13414
journal_title: Oncology Letters
journal_nlm_ta: Oncol Lett
publisher_name: D.A. Spandidos

keywords:
- Hedgehog
- glioblastoma
- Sonic
- patched-1
- smoothened
- drug resistance
- therapeutics

---
